MedPath
HSA Product

Topiron film-coated tablets 50mg

Product approved by Health Sciences Authority (SG)

Basic Information

Topiron film-coated tablets 50mg

TABLET, FILM COATED

Regulatory Information

SIN14131P

April 9, 2012

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XN03AX11

Company Information

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Active Ingredients

Topiramate

Strength: 50mg

Detailed Information

Contraindications

**4.3. Contraindications** Migraine prophylaxis: in pregnancy and in women of childbearing potential if not using a highly effective method of contraception. Hypersensitivity to the active substance or to any of the excipients.

Indication Information

**4.1. Therapeutic indications** Topiramate is indicated as monotherapy in adults and children with partial onset seizures and generalised seizures including tonic-clonic seizures. Topiramate is indicated as adjunctive therapy for adults and children with partial onset seizures or generalized tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. Topiramate is also indicated in adults for the prophylaxis of migraine headache. The usefulness of Topiramate in the acute treatment of migraine headache has not been studied.

© Copyright 2025. All Rights Reserved by MedPath